3.4.2025 08:38:16 CEST | Thor Medical ASA | Additional regulated information required to be disclosed under the laws of a member state
3 April 2025: Notice is given that the Annual General Meeting of Thor Medical ASA will be held on 24 April 2025, at 14:00 hours CEST at Advokatfirmaet Selmer, Ruseløkkveien 14, 0251 Oslo. The full notice and appendices are attached. The notice and the documents to which it refers are also available on www.thormedical.com.
DISCLOSURE REGULATION
This information is required to be disclosed under Section 5-12 of the Securities Trading Act.
CONTACTS
Brede Ellingsæter, CFOO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’.
Attachments
Download announcement as PDF.pdf
Thor Medical – Proposed resolutions for the AGM 2025 norsk.pdf
Thor Medical – Proposed resolutions for the AGM 2025 English.pdf
Thor Medical – Notice of AGM 2025 norsk.pdf
Thor Medical – Notice of AGM 2025 English.pdf
